New Novodiag® Carbar+ test allows rapid, cost-effective molecular testing for ‘superbacteria’ and associated drug resistance

Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, today announces the CE-IVD marking of Novodiag® CarbaR+. Novodiag®CarbaR+ is a single molecular test allowing fully automated detection of Carbapenemase-Producing Enterobacteriaceae (CPE), and associated resistance markers.

Source: New Stage

Smart Innovations  
Back


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed